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Abstract We find that the pi,6-GlcNAc transferase activity 
present in hog gastric mucosal microsomes converts the linear 
pentasaccharide GlcNAcpi-3Gaipi-4GlcNAcpi-3Gaipi-
4GlcNAc (1) in a site-specific way to the branch-bearing 
hexasaccharide GlcNAcpi-3(GlcNAcpl-6)Galpl-4GlcNACpi-
3Gaipi-4GlcNAc (2). The product is a positional isomer of 
GlcNACpi-3Gaipi-4GlcNAcpi-3(GlcNAcpi-6)Gaipi-4GlcNAc 
(3), reportedly formed from 1 by another polylactosamine pi,6-
GlcNAc transferase activity present in human serum (Leppanen 
et al., Biochemistry, 30 (1991) 9287). Combined use of the two 
kinds of activities gave in the present experiments the 
heptasaccharide GlcNAcpi-3(GlcNAcpi-6)Gaipi-4GlcNAcpi-
3(GlcNAcpi-6)Gaipi-4GlcNAc (4), in which one of the branches 
occupies the position of the branch in 2 and the other the position 
of the branch in 3. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Multiply branched polylactosaminoglycan backbones are 
expressed on proteins of murine and human embryonal carci-
noma cells [1-3], human erythrocytes [4] and the protozoan 
Trypanosoma brucei [5]. They are present also in glycolipids of 
human and rabbit erythrocytes [6,7], human placenta [8,9] and 
pancreatic carcinoma cells [10]. Most of them represent long 
polylactosamine chains, bearing short branches. 
The backbone branching is developmentally regulated in 
the course of murine embryonic development [11], in embry-
onal carcinoma cells [1,11] and in human erythrocytes [4,12]. 
A polylactosamine, carrying several short branches and deco-
rated by multiple sialyl Lewis x groups, was recently shown to 
be a nanomolar inhibitor of L-selectin-mediated adhesion of 
lymphocytes to the activated endothelium of blood vessel 
walls in vitro [13,14]. These observations prompt interest in 
synthesis of multiply branched polylactosamines. 
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Their biosynthesis involves main chain assembly by alter-
nating pi,3-GlcNAc- and pi,4-Gal-transfers, and ensuing 
branch generation by pi,6-GlcNAc transferases. One type of 
the branch-forming enzymes transfers characteristically to the 
inner Gal residue of Galpl-4GlcNACpi-3Gaipi-4GlcNAc 
[15-19], while the other type transfers to the Gal-residue of 
the trisaccharide GlcNAcpi-3Gaipi-4GlcNAc [20-23]. Here, 
we show that the latter type of activity, present in hog gastric 
mucosal microsomes [20], converts the linear pentasaccharide 
GlcNAcpi-3Gaipi-4GlcNAcpi-3Gaipi-4GlcNAc (1) in a 
site-specific way to the hexasaccharide GlcNAcpi-
3(GlcNAcpi-6)Gaipi-4GlcNAcpi-3Gaipi-4GlcNAc (2). Gly-
can 2 is an isomer of GlcNAcpi-3Gaipi-4GlcNAcpi-
3(GlcNAcpi-6)Gaipi-4GlcNAc (3), which is formed from 1 
by the mid-chain pi,6-GlcNAc transferase activity of human 
serum [15]. By combining the use of the two activities, we 
converted in the present experiments glycan 1 to the doubly 
branched heptasaccharide GlcNACpi-3(GlcNACpi-6)Gaipi-
4GlcNAcpi-3(GlcNAcpi-6)Gaipi-4GlcNAc (4), that bears 
both branches found in 2 and 3. A preliminary report of 
some of the data has appeared [24]. 
2. Materials and methods 
2.1. Oligosaccharides 
GlcNAcpi-3[3H]Gaipi-4GlcNAcpi-3[,4C]Gaipi-4GlcNAc (1) was 
synthesized as in [15] by using UDP-[14C]Gal in the first, and UDP-
[3H]Gal in the second galactosylation step; for the synthesis of the 
isotopomer GlcN Acp 1 - 3 Gaip 1 -4GlcN AcP 1 -3Galp 1 -4[14 C] GlcNAc, 
[14C]GlcNAc was used as acceptor in the first galactosylation step. 
UDP-Gal, UDP-GlcNAc, D-galactose, lactose and malto-oligosac-
charides were purchased from Sigma. UDP-[14C]Gal [14C]GlcNAc 
and UDP-[3H]Gal were from Amersham. 
2.2. Enzymic methods 
pi,6-GlcNAc transferase (EC 2..4.1.148) reactions were performed 
by incubating the saccharides with UDP-GlcNAc and hog gastric 
mucosal microsomes as in [25]. Treatment with endo-P-galactosidase 
(EC 3.2.1.103) from Bacteroides fragilis (Boehringer, Mannheim, Ger-
many) was performed as in [15]. Jack bean p-/V-acetylhexosaminidase 
(EC 3.2.1.30) digestions were performed as in [26]. 
2.3. Partial acid hydrolysis 
Partial acid hydrolysis was performed as in [25]. 
2.4. Chromatographic methods 
Paper chromatography was performed as in [15] by using the upper 
phase of «-butanol/acetic acid/water 4:1:5 by vol. (solvent A) or n-h\x-
tanol/ethanol/water 10:1:2 by vol. (solvent E). Biogel P-4 chromatog-
raphy was as in [26]. 
2.5. 'H-NMR experiments 
The 'H-NMR experiments were carried out as in [17]. 
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2.6. MALDI-TOF mass spectra 
The MALDI-TOF mass spectra were recorded as in [13]. 
3. Results 
3.1. Enzyme-assisted synthesis of hexasaccharide 2 
Incubation of the doubly labeled pentasaccharide 
GlcNAcpi-3[3H]Gaipi-4GlcNAcpi-3[14C]Gal|31-4GlcNAc (1) 
with UDP-GlcNAc and hog gastric mucosal microsomes, 
which contain pi,6-GlcNAc transferase activity [20], gave a 
product chromatographing like a hexasaccharide (Fig. 1A). 
Its partial acid hydrolysis gave 3H-labelled, but not 14C-la-
belled glycans that contained the newly formed GlcNAcpi-
6Gal bond. The cleavage products included the disaccha-
ride GlcNAcpi-6[3H]Gal, the trisaccharides GlcNAcpi-
6[3H]Galpl-4GlcNAc and GlcNAcpl-3(GlcNAcpl-6)[3H]Gal 
as well as the tetrasaccharide GlcNAcpi-3(GlcNAcpi-
6)[3H]Galpl-4GlcNAc (Fig. 2A). This established that the 
new branch had been formed solely at the 3H-labelled galac-
tose-4 of the acceptor (for numbering of the individual mono-
saccharide residues, see Table 1), generating GlcNAcpi-
3(GlcNAcpl-6)[3H]Galpl-4GlcNAcpl-3[14C]Gaipi-4GlcNAc 
(2). 
Preparative scale incubation of pentasaccharide 1 with 
UDP-GlcNAc and the gastric mucosal microsomes gave 
130 nmol of hexasaccharide 2 that was isolated by Bio-Gel 
P-4 chromatography. The 'H-NMR spectrum of 2 (Fig. 3A 
and Table 2) confirmed its structure. The spectrum revealed 
reporter group signals similar to those of glycan 1, but con-
tained also an additional one-proton doublet at 4.592 ppm, 
assigned to H-l of the pi,6-bonded GlcNAc-7. Interestingly, 
this signal is distinct from the H-l resonance of the (31,6-
linked GlcNAc in the tetrasaccharide GlcNAcpi-
3(GlcNAcpl-6)Galpl-4GlcNAc (8 = 4.585 ppm, [21]); it dif-
fers also from the H-l signal of the pi,6-bonded GlcNAc-6 
in the isomeric hexasaccharide GlcNAcpi-3Gaipi-
4GlcNAcpi-3(GlcNAcpi-6)Gaipi-4GlcNAc (3) (8 = 4.584 
Table 1 
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Fig. 1. Paper chromatography of synthetic polylactosamines in sol-
vent A. A: Glycans from incubation of GlcNAcBl-3[3H]Gaipi-
4GlcNAcpi-3[14C]Galpl-4GlcNAc (1) with UDP-GlcNAc and hog 
gastric mucosal microsomes. Peak 1 represents glycan 1 and peak 2 
is a hexasaccharide-like product. B: Oligosaccharides from incuba-
tion of GlcNAcpl-3(GlcNAcpi-6)[3H]Gaipi-4GlcNAcpl-3[14C]Gal-
P1-4G1CNAC (2) with UDP-GlcNAc and human serum. Peak 2 rep-
resents glycan 2 and peak 4 is a heptasaccharide-like product. 
C: Oligosaccharides from a prolonged incubation of GlcNAcpi-
3Gaipi-4GlcNAcpl-3Galpl-4[14C]GlcNAc (1) with UDP-GlcNAc 
and hog gastric mucosal microsomes. Peak 4 represents glycan 4, 
while peak 2 is believed to contain glycan 2 and related hexasac-
charides, and peak 1 probably represents a mixture of glycan 1 and 
the isomeric GlcNAcpi-6Gaipi-4GlcNAcpi-3Gaipi-4[14C]GlcNAc 
[27]. D: Oligosaccharides from an endo-p-galactosidase digest of the 
doubly branched glycan 4, GlcNAcpl-3(GlcNAcpl-6)Gaipi-
4GlcNACpi-3(GlcNAcpi-6)Gaipi-4[
14C]GlcNAc. The heptasaccha-
ride preserved its integrity during the enzyme treatment, and no 
[14C]GlcNAc was released. 
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Fig. 2. Paper chromatography (Solvent E) of degradation products 
from branched polylactosamines. A: Partial acid hydrolysate of 
the doubly labeled glycan GlcNAcpl-3(GlcNAcpl-6)[3H]Gaipi-
4GlcNAcpi-3[14C]Gaipi-4GlcNAc (2) of Fig. 1A. Among the 
hydrolysis products, peak 1 contained GlcNAcpi-3(GlcNAcpi-
6)[3H]Gaipi-4GlcNAc and GlcNAcpi-3(GlcNACpi-6)[
3H]Gal, peak 
2 represented GlcNAcpi-6[3H]Galpl-4GlcNAc, peak 3 contained 
GlcNAcpi-3[3H]Gaipi-4GlcNAc and GlcNAcpi-3[14C]Gaipi-
4GlcNAc, peak 4 was GlcNACpi-6[
3H]Gal, peak 5 was GlcNAcpi-
3[3H]Gal, while peak 6 represented [3H]Galpl-4GlcNAc and 
[14C]Galpl-4GlcNAc. B: Partial acid hydrolysate of GlcNAcpi-
3(GlcNAcP 1 -6)Gaip 1 -4GlcNAcP 1 -3(GlcNAcP 1 -6)Gaip 1 -4[14C]GlcN-
Ac (4) of peak 4 in Fig. 1C. Here, peak 1 represents GlcNAcpi-
3(GlcNAcpi-6)Galpl-4[14C]GlcNAc, peak 2 GlcNAcpi-6Gaipi-
4[14C]GlcNAc, peak 3 GlcNAcpi-3Gaipi-4[14C]GlcNAc and peak 6 
Gaipi-4[14C]GlcNAc. 
ppm, [19]). Even the H-l resonances, and likewise the H-4-
signals, of the two galactoses in glycan 2 were distinct, while 
in the parent pentasaccharide 1 they were not. 
The MALDI-TOF mass spectrum of glycan 2 revealed a 
major peak of monoisotopic m/z 1177.1 (not shown), that 
was assigned to (M+Na)+ of GlcNAc4Gal2 (calculated m/z 
1177.4). 
3.2. Enzyme-assisted synthesis of hexasaccharide 4 
Hexasaccharide 2 is a positional isomer of hexasaccha-
ride 3, GlcNAc(31-3Gaipi-4GlcNAcpi-3(GlcNAcpi-6)Gaipi-
4GlcNAc, which is formed from pentasaccharide 1 and UDP-
GlcNAc by the activity of a pi,6-GlcNAc transferase present 
in human serum [15]. We anticipated that the serum enzyme 
would transfer the branch to galactose-2 even in hexasacchar-
ide 2. Actual incubation of hexasaccharide 2 with UDP-
GlcNAc and human serum gave a product that chromato-
graphed like a heptasaccharide (Fig. IB). The branching 
rate of 2 was comparable to that of 1. 
A doubly branched heptasaccharide-like product was gen-
erated also in a prolonged incubation of the pentasaccha-
ride GlcNAcpi-3Gaipi-4GlcNAcpi-3Gaipi-4[14C]GlcNAc 
(1) with UDP-GlcNAc and the gastric mucosal microsomes 
(Fig. 1C). Partial acid hydrolysis of the heptasaccharide-like 
product (peak 4) released GlcNAcpl-3(GlcNAcpl-6)Gaipi-
4[14C]GlcNAc and GlcNACpi-6Gaipi-4[
14C]GlcNAc (Fig. 
2B); both cleavage products were converted quantitatively 
into Gaipi-4[14C]GlcNAc by P-Af-acetylhexosaminidase (not 
shown). These data establish that peak 4 in Fig. 1C contains 
the reducing end sequence GlcNAcpi-3(GlcNAcpl-6)Galpl-
4[14C]GlcNAc. Supporting this, peak 4 glycan resisted com-
pletely a treatment with endo-P-galactosidase (Fig. ID), 
while glycan 2, GlcNAcpi-3(GlcNACpi-6)Gaipi-4GlcNACpi-
3Gaipi-4[14C]GlcNAc was almost completely cleaved at the 
reducing end LacNAc, releasing [14C]GlcNAc in a parallel 
experiment (not shown). Branching is known to make glycans 
of this type resistant to endo-P-galactosidase [28]. Hence, peak 
4 in Fig. 1C represents the doubly branched saccharide 
GlcNAcpi-3(GlcNAcpi-6)Gaipi-4GlcNAcpi-3(GlcNAcpi-6) 
Gaipi-4[14C]GlcNAc (4), formed primarily along the pathway 
1 - 2 ^ 4 . 
Preparative scale incubation of the branched hexasaccha-
ride 2 (320 nmol) with UDP-GlcNAc and gastric mucosal 
microsomes, followed by gel filtration gave 8 nmol of the 
heptasaccharide 4. Its ^-NMR-spectrum (Fig. 3B and Table 
2) was identical to the spectrum of another sample of glycan 
4, synthesized recently in our laboratory along the pathway 
l -»3->4 [19]. In particular, two one-proton signals from 
pi,6-linked GlcNAc-units were observed in the present spec-
trum of 4. One of these (8 = 4.592 ppm) is assigned to 
GlcNAc-7 because it is identical with the corresponding signal 
of hexasaccharide 2. The other one (8 = 4.584 ppm) is assigned 
to H-l of GlcNAc-6 because of its similarity with the analo-
Table 2 
Chemical shifts of reporter groups in glycans 1-4. For glycan numbers and denotation, see Table 1 
Reporter group Residue Saccharides 
l a 
5.204(a) 
4.720(p) 
4.467 
4.703/4.698 
4.467 
4.680 
-
-
4.154 
4.154 
2 
5.206(a) 
4.721(p) 
4.465 
4.708/4.704 
4.456 
4.675 
-
4.592 
4.155 
4.145 
3a 
5.211(a) 
4.730(p) 
4.452 
4.697/4.692 
4.468 
4.681 
4.584 
-
4.146 
4.153 
4 
5.211(a) 
4.730(P) 
4.455 
4.703/4.697 
4.455 
4.675 
4.584 
4.592 
4.143 
4.143 
H-l 
H-4 
2 
3b 
4 
5 
6 
7 
2 
"Data from [19]. 
bThe two values given correspond to the two anomers of the oligosaccharide. 
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Fig. 3. Anomeric regions of 'H-NMR spectra of oligosaccharides synthesized in the present experiments A: Hexasaccharide 2. The signals 
marked by an asterisk (*) probably arise from the reducing-end ManNAc epimer of 2. (Similar resonances belonging to the reducing end 
monosaccharide were observed in an isomeric contaminant of a synthetic sample of GlcNAcpl-3Gaipi-4GlcNAc. The contaminant trisacchar-
ide was isolated chromatographically and degraded by a stepwise treatment with P-iV-acetylhexosaminidase and p-galactosidase. In Dionex 
chromatography, the reducing end monosaccharide co-migrated with the ManNAc marker.) B: Heptasaccharide 4. 
gous resonance of glycan 3 [13]. The conversion of l -»4 in-
volved equal upfield shifts of 0.012 ppm on the H-l signals of 
both galactoses, implying that both of them became branch-
bearing in the process. The conversion induced analogous 
shifts even at H-4 signals of the two galactoses. 
4. Discussion 
Here, we have found that the (31,6-GlcNAc transferase activ-
ity present in hog gastric mucosal microsomes converts the pen-
tasaccharide acceptor GlcNAc|31-3Gaipi-4GlcNAc|31-3Gal|31-
4GlcNAc (1) to the hexasaccharide GlcNAc|31-3(GlcNAc|31-
6)Gaipi-4GlcNAcPl-3Gaipi-4GlcNAc (2), rather than to the 
isomeric GlcNACpi-3Gaipi-4GlcNAcpl-3(GlcNAcpi-6)Gal 
pl-4GlcNAc (3). The present experiments involved (i) the use 
of synthetic acceptor molecules that were radiolabeled in ap-
propriate monosaccharide residues and (ii) degradation as 
well as 'H-NMR spectroscopy of the branch-bearing prod-
ucts. The data extend the observations of Piller et al. [20], 
who had shown that the hog gastric mucosal microsomes 
transfer from UDP-[14C]GlcNAc to P-methylglycoside of gly-
can 1, but had not established the structure of the product. 
It is now clear that the gastric mucosal activity transfers 
pi,6-bonded GlcNAc units to the trisaccharide GlcNAcpi-
/ Helin et al.lFEBS Letters 412 (1997) 637-642 641 
3GalBl-4GlcNAc [20,21] as well as to the pentasaccharide 
GlcNAcBl-3GalBl-4GlcNAcBl-3GalBl-4GlcNAc (1) at the 
galactose units in bold print. The present data, showing that 
the primary reaction with glycan 1 site-specifically does not 
involve galactose-2, suggest that the primary reaction is over-
whelmingly restricted to distal GlcNAcBl-3GalBl-4GlcNAc 
determinants in polylactosamines. This conclusion is sup-
ported by the data of Piller et al. [20] who did not find any 
transfer to the methyl glycoside of GalBl-4GlcNAcBl-
3GalBl-4GlcNAc. Accordingly, we call the gastric mucosal 
activity as a distal Bl,6-GlcNAc transferase, in short dIGnT6, 
to emphasize its site-specific action and the fact that it gen-
erates precursors of blood group I type polylactosamines. 
The hexasaccharide 2 represents a positional isomer of hex-
asaccharide 3. The latter one has been synthesized previously 
from pentasaccharide 1 by using the activity of another type 
of Bl,6-GlcNAc transferase, which is present in blood serum 
of mammals [15,19]. The serum activity transfers in the first 
place only to galactose residues that belong to other than the 
most distal LacNAc unit of the acceptor. Examples of good 
acceptors are glycan 1 and the tetrasaccharide GalBl-
4GlcNAcBl-3GalBl-4GlcNAc at galactose-2 [17,18] as well 
as the hexasaccharide GalBl-4GlcNAcBl-3GalBl-4GlcNAc 
Bl-3GalBl-4GlcNAc at galactose-2 and galactose-4 [19]. We 
call this activity as central Bl,6-GlcNAc transferase (cIGnT6) 
to emphasize its area-specific action on polylactosamine 
chains. 
In a complementary experiment, advantage was taken of 
the alternative site-specificities of dIGnT6 and cIGnT6. The 
dIGnT6 activity of hog gastric mucosal microsomes was first 
used to convert the pentasaccharide 1 into the branch-bearing 
hexasaccharide 2, and the latter was then converted into the 
doubly branched heptasaccharide 4 by the cIGnT6 activity of 
serum. In analogous complementary experiments described 
elsewhere [13], the nonasaccharide GlcNAcBl-3'LacNAcBl-
3'(GlcNAcBl-6')LacNAcBl-3'(GlcNAcBl-6')LacNAc with 
two 'central' branches was generated with the aid of serum 
cIGnT6 activity; subsequently the dIGnT6 activity of hog 
gastric mucosal microsomes was used to transfer the distal 
branch, generating the triply branched decasaccharide 
GlcNAcBl-3'(GlcNAcBl-6')LacNAcBl-3'(GlcNAcBl-6')Lac-
NAcBl-3'(GlcNAcBl-6')LacNAc. In the future, the use of the 
two IGnT6 activities of complementary site-specificities, to-
gether with improving availability of chemically synthesized 
long-chain polylactosamines [29], will probably pave synthetic 
routes to multiply branched backbones similar to those be-
lieved to be expressed in glycoproteins [3,4]. 
Besides the strong dIGnT6 activity, we find also the pres-
ence of a weak cIGnT6 activity in hog gastric mucosal micro-
somes, catalyzing the conversion 2->4. A little surprisingly, 
this activity did not catalyze detectable 1 -> 3 conversion. Per-
haps, the formation of glycan 4 was more easily detected in 
our experiments than the generation of glycan 3; alternatively, 
the conversion 2->4 was faster than the conversion of l - » 3 . 
Presently, it is not clear whether the activities of dIGnT6 and 
cIGnT6 in the gastric mucosal microsomes are due to one or 
several enzymes. 
Taken together, the present data represent an accurate de-
scription of in vitro biosynthesis of a long polylactosamine 
chain carrying two short branches that are transferred to 
the primary chain sequentially and site-specifically by using 
two distinct types of polylactosamine Bl,6-GlcNAc transfer-
ase activities. The dIGnT6 activity present in hog gastric mu-
cosal microsomes transfers preferentially to one single site 
close to the distal area of the acceptor, requiring the non-
reducing-end sequence GlcNAcBl-3Gal-R. By contrast, the 
cIGnT6 activity present in mammalian serum and in several 
rat tissues [15,16,19] transfers preferentially to multiple central 
sites of the backbone acceptor, tolerating GlcNAcBl-3Gal-R 
as well as GalBl-4GlcNAc-R sequences at the non-reducing 
end of the acceptor. 
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